Video
Statin use linked with better outcomes in patients starting ADT for prostate cancer
Author(s):
“We continue to see a building story of benefit of statin medications in men who have prostate cancer,” says Robert J. Hamilton, MD, MPH.
Video Player is loading.
In this interview, Robert J. Hamilton, MD, MPH, discusses findings from a recent study published in European Urology titled, “The Association Between Statin Use and Outcomes in Patients Initiating Androgen Deprivation Therapy,” for which he served as a study author. Hamilton is an associate professor of urology at the University of Toronto.
More videos:
Clinical care pathway demonstrates efficacy for patients with overactive bladder
Analysis underscores importance of pretreatment urine cultures in patients with recurrent UTI
Related Videos
Suzanne B. Merrill, MD, FACS, discusses rBCG and the NMIBC landscape
Ekene Enemchukwu, MD, on the need for better education on GSM, vaginal estrogen
Urologist discusses drug cost savings, price transparency
Neeraj Agarwal, MD, shares key takeaways from TALAPRO-2
Expert describes implications of neoadjuvant durvalumab approval in MIBC
Ian Metzler, MD, highlights recent advances in kidney stone technology
Ekene Enemchukwu, MD, on underutilization of vaginal estrogen for GSM
Sima Porten, MD, on gene-environment interactions in bladder cancer development
Naeem Bhojani, MD, expands on key findings from WATER III trial
Hailey Frye discusses improvement of pain management for nephrolithiasis
Related Content
